Julie St. John

701 total citations
24 papers, 461 citations indexed

About

Julie St. John is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Julie St. John has authored 24 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Julie St. John's work include Lipoproteins and Cardiovascular Health (7 papers), Coronary Interventions and Diagnostics (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Julie St. John is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Coronary Interventions and Diagnostics (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Julie St. John collaborates with scholars based in United States, Australia and United Kingdom. Julie St. John's co-authors include Stephen J. Nicholls, Rishi Puri, Steven E. Nissen, E. Murat Tuzcu, Steven E. Nissen, Mohamed B. Elshazly, Kiyoko Uno, Samir Kapadia, Yu Kataoka and Kathy Wolski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Julie St. John

21 papers receiving 458 citations

Peers

Countries citing papers authored by Julie St. John

Since Specialization

Citations

This map shows the geographic impact of Julie St. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie St. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie St. John more than expected).

Fields of papers citing papers by Julie St. John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie St. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie St. John. The network helps show where Julie St. John may publish in the future.

Co-authorship network of co-authors of Julie St. John

This figure shows the co-authorship network connecting the top 25 collaborators of Julie St. John. A scholar is included among the top collaborators of Julie St. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie St. John. Julie St. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants 2025 ·Journal of Clinical Hypertension ·(unknown), Julie St. John, (unknown), Ashish Sarraju, Luke J. Laffin	0
2	Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trial 2025 ·Atherosclerosis ·Tom Kai Ming Wang, Stephen J. Nicholls, Julie St. John, Kathy Wolski, Steven E. Nissen	0
3	Blood Pressure Time in Target Range and its Impact on Clinical Outcomes 2024 ·Current Cardiology Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Julie St. John, Luke J. Laffin	3
4	Association of pulse pressure with death, myocardial infarction, and stroke among cardiovascular outcome trial participants 2023 ·SHILAP Revista de lepidopterología ·(unknown), Julie St. John, Erik H. Van Iterson, Luke J. Laffin	3
5	Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial 2020 ·BMJ Open Diabetes Research & Care ·Venu Menon, Anirudh Kumar, Divyang Patel, Julie St. John, Jeffrey Riesmeyer, Govinda J. Weerakkody, Giacomo Ruotolo, Kathy Wolski, Ellen McErlean, Paul Cremer, Stephen J. Nicholls, A. Michael Lincoff, Steven E. Nissen	19
6	C-REACTIVE PROTEIN LEVELS MODULATE LIPOPROTEIN(A)-ASSOCIATED CARDIOVASCULAR RISK IN OPTIMALLY-TREATED PATIENTS WITH HIGH-RISK VASCULAR DISEASE 2019 ·Journal of the American College of Cardiology ·Rishi Puri, Steven E. Nissen, Benoît Arsenault, Julie St. John, Jeffrey Riesmeyer, Giacomo Ruotolo, Leslie Cho, Venu Menon, A. Michael Lincoff, Stephen J. Nicholls	3
7	ORAL CALCIUM SUPPLEMENTS ASSOCIATE WITH SERIAL CORONARY CALCIFICATION: INSIGHTS FROM INTRAVASCULAR ULTRASOUND 2019 ·Journal of the American College of Cardiology ·Najdat Bazarbashi, Rishi Puri, Stephen J. Nicholls, Julie St. John, Mohamed M. Gad, Manpreet Kaur, (unknown), Yasser Sammour, Keerat Rai Ahuja, E. Murat Tuzcu, Steven E. Nissen, Samir Kapadia	2
8	Visit-to-Visit Blood Pressure Variability, Coronary Atheroma Progression, and Clinical Outcomes 2019 ·JAMA Cardiology ·Donald M. Clark, Stephen J. Nicholls, Julie St. John, Mohamed B. Elshazly, Haitham M. Ahmed, Haitham Khraishah, Steven E. Nissen, Rishi Puri	65
9	3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE 2017 ·European Heart Journal ·Venu Menon, A. Michael Lincoff, Stephen J. Nicholls, Philip J. Barter, Bryan Brewer, Keith A.A. Fox, C. Michael Gibson, Christopher B. Granger, Gilles Montalescot, Daniel J. Rader, Alan R. Tall, Giacomo Ruotolo, (unknown), Julie St. John, Steven E. Nissen	1
10	Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events 2016 ·The American Journal of Cardiology ·Mohamed B. Elshazly, Stephen J. Nicholls, Steven E. Nissen, Julie St. John, Seth S. Martin, Steven R. Jones, Renato Quispe, Brian Stegman, Samir Kapadia, E. Murat Tuzcu, Rishi Puri	21
11	Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe 2016 ·The American Journal of Cardiology ·Rishi Puri, Stephen J. Nicholls, Julie St. John, E. Murat Tuzcu, Samir Kapadia, Kiyoko Uno, Yu Kataoka, Kathy Wolski, Steven E. Nissen	3
12	A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety 2015 ·Journal of Interventional Cardiac Electrophysiology ·Mohammed Qintar, (unknown), (unknown), (unknown), (unknown), Julie St. John, (unknown), Elizabeth Ching, Samuel F. Sears, Susanne S. Pedersen, (unknown), Mina K. Chung	22
13	Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography 2015 ·International journal of cardiac imaging ·Muhammad Hammadah, Mohammed Qintar, Steven E. Nissen, Julie St. John, (unknown), (unknown), Femi Philip, Kiyoko Uno, Yu Kataoka, (unknown), (unknown), Samir Kapadia, E. Murat Tuzcu, Paul Schoenhagen, Stephen J. Nicholls, Rishi Puri	4
14	External validation of the HIT Expert Probability (HEP) score 2015 ·Thrombosis and Haemostasis ·Lee Joseph, Marcelo Gomes, (unknown), Elisabet Miró‐Casas, Julie St. John, (unknown), (unknown), (unknown), Esther S.H. Kim	19
15	Atheroma Progression in Hyporesponders to Statin Therapy 2015 ·Arteriosclerosis Thrombosis and Vascular Biology ·Yu Kataoka, Julie St. John, Kathy Wolski, Kiyoko Uno, Rishi Puri, E. Murat Tuzcu, Steven E. Nissen, Stephen J. Nicholls	46
16	Relation of High-Density Lipoprotein Cholesterol:Apolipoprotein A-I Ratio to Progression of Coronary Atherosclerosis in Statin-Treated Patients 2014 ·The American Journal of Cardiology ·Preethi Mani, Kiyoko Uno, Julie St. John, E. Murat Tuzcu, Steven E. Nissen, Stephen J. Nicholls	16
17	Factors underlying regression of coronary atheroma with potent statin therapy 2013 ·European Heart Journal ·Rishi Puri, Steven E. Nissen, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Julie St. John, Kathy Wolski, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	59
18	LARGER LIPID POOLS ASSOCIATE WITH FEATURES OF PLAQUE VULNERABILITY ON OPTICAL COHERENCE TOMOGRAPHY 2013 ·Journal of the American College of Cardiology ·Yu Kataoka, Julie St. John, Kathy Wolski, Kiyoko Uno, Rishi Puri, James E. Harvey, Samir Kapadia, E. Murat Tuzcu, Steven E. Nissen, Stephen J. Nicholls	2
19	External Validation Of The HIT Expert Probability (HEP) Score, a Novel Pre-Test Probability Model For Heparin-Induced Thrombocytopenia Based On Broad Expert Opinion 2013 ·Blood ·Lee Joseph, Marcelo Gomes, (unknown), Julie St. John, (unknown), (unknown), (unknown), Esther S.H. Kim	0
20	Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension 2011 ·Expert Review of Clinical Pharmacology ·Julie St. John, Harold I. Palevsky	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact